Recently, the book "China Drug Administration Yearbook" (2021) published by the National Medical Products Administration was officially released. Tianjiquan Group has been included in this yearbook multiple times due to its good corporate image, high-quality health products, and excellent services. This not only demonstrates the outstanding achievements of Tianjiquan Group in developing innovative products and the strong strength of the brand, but also once again proves the recognition of Tianjiquan Group by the National Medical Products Administration, which is of great significance!

China Drug Administration Yearbook (2021)

The book "China Drug Administration Yearbook" (2021) focuses on the Tianjiquan G SLT semiconductor laser therapy device. Semiconductor laser therapy device is non-invasive and infection free; Small size and light weight, easy to operate, not limited by time or location; Laser irradiation of the nasal cavity or acupoints is used as an adjuvant therapy for vascular headaches, cerebral infarction, and chronic cardiovascular and cerebrovascular diseases after traumatic brain injury.

China Drug Administration Yearbook (2021) Tianjiquan Page Details

The China Drug Administration Yearbook is a large-scale informational and data tool that comprehensively reflects the safety supervision and management of food, drugs, medical devices, health food, and cosmetics in China, including progress and achievements. The first volume was published in 1999. The China Drug Administration Yearbook highlights accuracy, authority, usage, and continuity. The main distribution targets include food and drug regulatory agencies at all levels, catering service enterprises, pharmaceutical, medical device, health food, cosmetics production and operation enterprises and inspection units, relevant research institutes, colleges and universities, hospitals, Xinhua Bookstore, and various libraries.

China Drug Administration Yearbook (2021) Tianjiquan Page Details

Tianjiquan has an independent research and development production base to provide guarantees for technology research and development, product testing, and insists on using innovative technology to create ultimate health products. It has developed multiple health technology products and officially launched them on the Shenzhen government procurement platform. It has been successfully selected for the "2022 Elderly Products Promotion Catalogue" by the Ministry of Industry and Information Technology of China. In addition, with its high-precision technology, Tianjiquan Group has also won multiple honorary titles such as "EU CE Certification", "Medical Device Import License" from South Korea, "National High tech Enterprise", "China's Most Influential Innovation Achievement Award", "South Africa Outstanding Science and Technology Achievement Award", "Thailand Inventor's Day China Good Technology Exhibition Gold Award", and has won excellent awards at multiple high-tech fairs in 2010, 2011, 2012, etc. Product Award.

The board of directors of Tianjiquan Group attaches great importance to product innovation and research and development

Since its establishment more than 20 years ago, Tianjiquan Group has always adhered to the original intention of "boundless love, spreading health; unique goal, treating diseases and saving lives", down-to-earth, adapting to the market and innovating, accumulating rich experience and strong strength. The inclusion of the book "China Drug Administration Yearbook" (2021) is a great event for the development of Tianjiquan Group's business, a blessing for the inheritance of corporate culture, and another milestone representing Tianjiquan Group's efforts to help the big health industry reach a new level.

In the future, Tianjiquan Group will play a leading role, lead the development of the industry, continue to focus on the accumulated brand and cultural advantages of the big health industry, always adhere to the original mission, strive to improve the level of scientific and technological research and development, develop more and better health products to serve the public, fully leverage the advantages and exemplary leading role of high-tech enterprises, never forget the original intention, forge ahead, and contribute to the construction of a healthy China!